Dualitybio Inc.

This study is testing two different drug combinations for people with advanced solid tumors that have spread or returned after treatment. Researchers will give participants either DB-1311 with BNT327 or DB-1311 with DB-1305 to see how safe these combinations are and if they can s…

This is the first human study of an experimental drug called DB-1317 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in about 233 participants to find the safest amount and see if the drug can shrin…

This is the first study in people testing a new drug called DB-1419 for adults with advanced or spreading solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it ca…

This early-stage study is testing a new drug called DB-2304 for lupus. It will first check the drug's safety and side effects in healthy volunteers, then in people with lupus. The main goal is to see how well the body tolerates the drug and how it behaves in the bloodstream.

This is a first-in-human study to test the safety and find the right dose of a new investigational drug called DB-1311 for people with advanced solid tumors that have progressed after standard treatments. The trial will enroll adults with various cancers to see how their bodies h…

This is the first human study of an experimental drug called DB-1303 for people with advanced HER2-positive solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how well the body handles the drug. Researchers will also l…